Glinta Plus Tablet 25 mg+5 mg is a combination oral antidiabetic medication containing Empagliflozin (25 mg) and Linagliptin (5 mg). This dual-action therapy is designed for the management of type 2 diabetes mellitus, providing comprehensive blood sugar control through two complementary mechanisms. Linagliptin enhances insulin secretion and suppresses excessive glucagon release, while Empagliflozin promotes glucose excretion via the kidneys. Together, they help achieve better glycemic control, both fasting and postprandial, with a low risk of hypoglycemia.

This higher-dose combination is especially useful for patients requiring intensified therapy for improved blood sugar management beyond monotherapy or lower-dose combinations.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Glinta Plus Tablet 25 mg+5 mg is indicated for:

• Type 2 diabetes mellitus – For patients inadequately controlled with diet, exercise, or lower-dose therapies.

• Combination therapy – Can be combined with other antidiabetic medications under medical supervision.

• Prevention of complications – Maintaining stable blood sugar helps reduce the risk of cardiovascular, kidney, and nerve complications associated with diabetes.

Mechanism of Action

The combination provides complementary actions to control blood sugar effectively:

• Linagliptin (DPP-4 inhibitor): Increases incretin hormone levels, stimulating insulin secretion after meals and reducing glucagon secretion, improving postprandial glucose control.

• Empagliflozin (SGLT2 inhibitor): Inhibits renal glucose reabsorption, promoting the excretion of excess glucose through urine, reducing blood sugar independently of insulin.

This dual mechanism addresses both insulin-dependent and insulin-independent pathways, providing enhanced glycemic management.

Dosage and Administration

• Recommended dose: One tablet daily, with or without food, preferably at the same time each day.

• Administration: Swallow the tablet whole; do not crush or chew to maintain effectiveness.

• Monitoring: Regular blood glucose and kidney function tests are advised to ensure safety and efficacy.

Precautions and Warnings

• Kidney impairment: Empagliflozin is not recommended in severe renal dysfunction; monitoring is necessary.

• Hypoglycemia: Risk is low when used alone but may increase if combined with insulin or sulfonylureas.

• Dehydration: Increased urination may occur; maintain adequate fluid intake.

• Pregnancy and breastfeeding: Only use under medical supervision.

• Drug interactions: Inform your healthcare provider of all medications being taken.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Side Effects

Common side effects may include:

• Increased urination or urinary tract infections

• Nasopharyngitis (cold-like symptoms)

• Mild gastrointestinal discomfort

• Headache or dizziness

Severe side effects are rare but require prompt medical attention.

Storage

Store Glinta Plus Tablet 25 mg+5 mg in a cool, dry place below 25°C, protected from moisture and sunlight. Keep out of reach of children.

Conclusion

Glinta Plus Tablet 25 mg+5 mg by SK Pharma offers an advanced dual-action solution for managing type 2 diabetes. Its combination of Linagliptin and Empagliflozin ensures comprehensive blood sugar control by targeting both insulin-dependent and insulin-independent pathways, reducing glucose fluctuations and supporting long-term glycemic stability. Proper adherence, regular monitoring, and a healthy lifestyle maximize the safety and effectiveness of this therapy.